Broadlane, San Francisco, a full-service group purchasing organization, and Biosite, San Diego, a research-centered company developing protein-based diagnostic tests, have signed a three-year purchasing agreement. Under the terms, Biosite will give Broadlane's hospital customers preferred pricing for its Triage BNP Test, which aids in the detection of congestive heart failure. The agreement also covers other Biosite one-of-a-kind tests developed to help improve the ability to diagnose debilitating and life-threatening diseases. -- by Cinda Becker
Broadlane signs pact with test-developer Biosite
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.